How to read the evidence on any peptide

Peptide marketing runs on confident language and borrowed credibility. The best protection isn't a list of 'good' and 'bad' peptides, it's knowing how to read the evidence yourself. Here is the short version we use on every page of this site.

1. Find the regulatory status first

Before any claim, ask one question: is this FDA-approved, or compounded? An FDA-approved medicine has been reviewed by the FDA for safety, effectiveness and quality. A compounded preparation is made by a licensed pharmacy against your prescription and is not FDA-approved, which means the FDA did not review that specific preparation. Both can be lawful. They are not the same thing, and any honest source tells you which one you are looking at.

2. Ask where the evidence comes from

'Studied' is doing a lot of work in most peptide marketing. There is a world of difference between a large randomized human trial and a mouse study. Our evidence pages grade each compound A to D for exactly this reason: A is strong human evidence (large randomized trials), B is moderate human data, C is limited or mixed human trials, and D is preclinical only, meaning animal or lab work with no human efficacy trials yet. When something is only animal data, we say 'not tested in people' rather than implying an effect.

3. Watch for the common tells

• 'Approved in another country' is not the same as FDA or EMA approval, especially when the trials come from the same group that makes the compound.
• 'Natural peptide fragment' does not mean safe — a synthetic analog needs its own safety evaluation.
• 'Promising research' usually means animal research. Most compounds that look good in mice do not survive human testing.
• A named effect with no citation is a claim, not evidence. Look for the primary source, and whether it was in people.

4. Check the sport and safety flags

If you compete, assume a non-approved substance is prohibited until you have confirmed otherwise with Global DRO or USADA. And for any compound with thin human data, the real question is not 'could it help' but 'what is unknown' — long-term safety data simply does not exist for many of these.

This is how to judge any clinic, including ours. If a site will not tell you plainly whether something is approved or compounded, and whether the evidence is human or animal, that absence is itself the answer.

Put it to work: browse the graded evidence, start with the peptide library, or read how the FDA sees peptide medicines.